Literature DB >> 32234490

From Association to Causality: the Role of the Gut Microbiota and Its Functional Products on Host Metabolism.

Ara Koh1, Fredrik Bäckhed2.   

Abstract

Many genomic studies have revealed associations between the gut microbiota composition and host metabolism. These observations led to the idea that a causal relationship could exist between the microbiota and metabolic diseases, a concept supported by studies showing compositional changes in the microbial community in metabolic diseases and transmissibility of host phenotype via microbiota transfer. Accumulating data suggest that the microbiota may affect host metabolic phenotypes through the production of metabolites. These bioactive microbial metabolites, sensitive fingerprints of microbial function, can act as inter-kingdom signaling messengers via penetration into host blood circulation and tissues. These fingerprints may be used for diagnostic purposes, and increased understanding of strain specificity in producing microbial metabolites can identify bacterial strains or specific metabolites that can be used for therapeutic purposes. Here, we will review data supporting the causal role of the gut microbiota in metabolism and discuss mechanisms and potential clinical implications.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32234490     DOI: 10.1016/j.molcel.2020.03.005

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  50 in total

1.  The gut microbiota may be a novel pathogenic mechanism in loosening of orthopedic implants in rats.

Authors:  Meghan M Moran; Brittany M Wilson; Jun Li; Phillip A Engen; Ankur Naqib; Stefan J Green; Amarjit S Virdi; Anna Plaas; Christopher B Forsyth; Ali Keshavarzian; Dale R Sumner
Journal:  FASEB J       Date:  2020-09-15       Impact factor: 5.191

Review 2.  Combined use of lactic-acid-producing bacteria as probiotics and rotavirus vaccine candidates expressing virus-specific proteins.

Authors:  Atefeh Afchangi; Tayebeh Latifi; Somayeh Jalilvand; Sayed Mahdi Marashi; Zabihollah Shoja
Journal:  Arch Virol       Date:  2021-02-03       Impact factor: 2.574

Review 3.  Microbiota-derived tryptophan metabolites in vascular inflammation and cardiovascular disease.

Authors:  Nadja Paeslack; Maximilian Mimmler; Stefanie Becker; Zhenling Gao; My Phung Khuu; Amrit Mann; Frano Malinarich; Tommy Regen; Christoph Reinhardt
Journal:  Amino Acids       Date:  2022-04-22       Impact factor: 3.520

4.  The Pediatric Obesity Microbiome and Metabolism Study (POMMS): Methods, Baseline Data, and Early Insights.

Authors:  Jessica R McCann; Nathan A Bihlmeyer; Kimberly Roche; Cameron Catherine; Jayanth Jawahar; Lydia Coulter Kwee; Noelle E Younge; Justin Silverman; Olga Ilkayeva; Charles Sarria; Alexandra Zizzi; Janet Wootton; Lisa Poppe; Paul Anderson; Michelle Arlotto; Zhengzheng Wei; Joshua A Granek; Raphael H Valdivia; Lawrence A David; Holly K Dressman; Christopher B Newgard; Svati H Shah; Patrick C Seed; John F Rawls; Sarah C Armstrong
Journal:  Obesity (Silver Spring)       Date:  2021-03       Impact factor: 5.002

Review 5.  Roles for the gut microbiota in regulating neuronal feeding circuits.

Authors:  Kristie B Yu; Elaine Y Hsiao
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

Review 6.  Approaching precision medicine by tailoring the microbiota.

Authors:  Gaeun Ryu; Hyojin Kim; Ara Koh
Journal:  Mamm Genome       Date:  2021-03-01       Impact factor: 2.957

Review 7.  Revisiting fibrosis in inflammatory bowel disease: the gut thickens.

Authors:  Silvia D'Alessio; Federica Ungaro; Daniele Noviello; Sara Lovisa; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-12-07       Impact factor: 46.802

Review 8.  Classification, structure and mechanism of antiviral polysaccharides derived from edible and medicinal fungus.

Authors:  Yuxi Guo; Xuefeng Chen; Pin Gong
Journal:  Int J Biol Macromol       Date:  2021-05-25       Impact factor: 8.025

9.  Design of synthetic human gut microbiome assembly and butyrate production.

Authors:  Ryan L Clark; Bryce M Connors; David M Stevenson; Susan E Hromada; Joshua J Hamilton; Daniel Amador-Noguez; Ophelia S Venturelli
Journal:  Nat Commun       Date:  2021-05-31       Impact factor: 14.919

10.  Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity.

Authors:  Angélica Cruz-Lebrón; Ramona Johnson; Claire Mazahery; Zach Troyer; Samira Joussef-Piña; Miguel E Quiñones-Mateu; Christopher M Strauch; Stanley L Hazen; Alan D Levine
Journal:  Gut Microbes       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.